AIDX · 20/20 Biolabs, Inc.
$0.49
-0.02 (-4.10%)
At close · Jul 24
Market Cap
$5.21M
Shares
10.61M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$2.05M
+16.7%
FY2025
Net Income
-$3.74M
+32.7%
FY2025
Gross Margin
29.56%
+9pp
FY2025
Operating Margin
-162.87%
+161.1pp
FY2025
Diluted EPS
-$0.76
+34.5%
FY2025
Operating Cash Flow
-$1.92M
+26.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 |
|---|---|---|
| $2.05M | $1.75M | |
| $1.44M | $1.39M | |
| $604.54K | $360.31K | |
| 29.56% | 20.56% | |
| $592.57K | $1.26M | |
| $3.34M | $4.76M | |
| $22.5K | $22.5K | |
| $63.26K | $116.04K | |
| $3.94M | $6.04M | |
| -$3.33M | -$5.68M | |
| -162.87% | -323.99% | |
| -$3.27M | -$5.56M | |
| $156.21K | $12.65K | |
| $21.4K | $79.47K | |
| -$407.95K | $125.75K | |
| -$3.74M | -$5.55M | |
| -182.82% | -316.81% | |
| USD/shares | -$0.76 | -$1.16 |
| USD/shares | -$0.76 | -$1.16 |
| shares | 4.93M | 4.8M |
| shares | 4.93M | 4.8M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 |
|---|---|---|
| OneTest | $1,803,707 | $1,490,881 |
| BioCheck | $152,047 | $177,283 |
| CLIAx | $89,379 | $84,179 |